LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 157

Search options

  1. Article ; Online: COVID-19 mortality sentinel surveillance at a tertiary referral hospital in Lusaka, Zambia, 2020-2021.

    Hines, Jonas Z / Kapombe, Priscilla / Mucheleng'anga, Adam / Chanda, Stephen L / Hamukale, Amos / Cheelo, Mweene / Kamalonga, Kashala / Tally, Leigh / Monze, Mwaka / Kapina, Muzala / Agolory, Simon / Auld, Andrew F / Lungu, Patrick / Chilengi, Roma

    PLOS global public health

    2024  Volume 4, Issue 3, Page(s) e0003063

    Abstract: Deaths from COVID-19 likely exceeded official statistics in Zambia because of limited testing and incomplete death registration. We describe a sentinel COVID-19 mortality surveillance system in Lusaka, Zambia. We analyzed surveillance data on deceased ... ...

    Abstract Deaths from COVID-19 likely exceeded official statistics in Zambia because of limited testing and incomplete death registration. We describe a sentinel COVID-19 mortality surveillance system in Lusaka, Zambia. We analyzed surveillance data on deceased persons of all ages undergoing verbal autopsy (VA) and COVID-19 testing at the University Teaching Hospital (UTH) mortuary in Lusaka, Zambia, from April 2020 through August 2021. VA was done by surveillance officers for community deaths and in-patient deaths that occurred <48 hours after admission. A standardized questionnaire about the circumstances proximal to death was used, with a probable cause of death assigned by a validated computer algorithm. Nasopharyngeal specimens from deceased persons were tested for COVID-19 using polymerase chain reaction and rapid diagnostic tests. We analyzed the cause of death by COVID-19 test results. Of 12,919 deceased persons at UTH mortuary during the study period, 5,555 (43.0%) had a VA and COVID-19 test postmortem, of which 79.7% were community deaths. Overall, 278 (5.0%) deceased persons tested COVID-19 positive; 7.1% during waves versus 1.4% during nonwave periods. Most (72.3%) deceased persons testing COVID-19 positive reportedly had fever, cough, and/or dyspnea and most (73.5%) reportedly had an antemortem COVID-19 test. Common causes of death for those testing COVID-19 positive included acute cardiac disease (18.3%), respiratory tract infections (16.5%), other types of cardiac diseases (12.9%), and stroke (7.2%). A notable portion of deceased persons at a sentinel site in Lusaka tested COVID-19 positive during waves, supporting the notion that deaths from COVID-19 might have been undercounted in Zambia. Many had displayed classic COVID-19 symptoms and been tested before death yet nevertheless died in the community, potentially indicating strained medical services during waves. The high proportion of cardiovascular diseases deaths might reflect the hypercoagulable state during severe COVID-19. Early supportive treatment and availability of antivirals might lessen future mortality.
    Language English
    Publishing date 2024-03-29
    Publishing country United States
    Document type Journal Article
    ISSN 2767-3375
    ISSN (online) 2767-3375
    DOI 10.1371/journal.pgph.0003063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Effect of Centruroides antivenom on reversal of methamphetamine-induced hyperkinesis and hyperthermia in rats.

    Malekzadeh, Pouran / Hu, Jackie / Sandweiss, Alexander J / Ameli, Nina / Bierny, Philippe / Largent-Milnes, Tally M / Vanderah, Todd W / Shirazi, Farshad

    Journal of pharmaceutics & pharmacology

    2017  Volume 5, Issue 1

    Abstract: ... by scorpion AV equine immune F(ab')2 in rats.: Materials and methods: Baseline core temperature and ... 20 mg/kg, intraperitoneally, i.p.) + MA (10 mg/kg, i.p.) or control. Core body temperature was ...

    Abstract Context: Methamphetamine (MA) toxicity is a major health concern causing agitation, hyperkinesia, hyperthermia, and even death, affecting 24.7 million people worldwide. It has been observed that MA generates movement disorders in children similar to that of scorpion envenomation. Four cases have been reported where MA intoxication in children were both subjectively and objectively improved as indicated by the reversal of nystagmus and movement disorders following administration of Centruroides antivenom (AV) therapy.
    Objective: Here, we aimed to demonstrate the reversal of MA induced movement disorders and hyperthermia by scorpion AV equine immune F(ab')2 in rats.
    Materials and methods: Baseline core temperature and locomotor activity in adult male Sprague-Dawley rats (200-220 g) were evaluated prior to acute administration of AV (20 mg/kg, intraperitoneally, i.p.) + MA (10 mg/kg, i.p.) or control. Core body temperature was reassessed 10, 50, and 80 min post injection while locomotor activity was reassessed 20-35 and 60-75 min post injection.
    Results: At 20-35 min, Saline + MA and BSA + MA groups showed a significant increase in the number of fine events compared to their respective control groups Saline + Saline and BSA + Saline, which indicates an increase in paw movements of animals
    Discussion: Here, we provide evidence for some aspects of MA-induced hyperkinesia but not hyperthermia reversed by scorpion AV. Further preclinical studies involving adolescent rodents may be necessary to completely mimic the reversal of MA toxicity seen in children in the clinic.
    Language English
    Publishing date 2017-04-20
    Publishing country United States
    Document type Journal Article
    ISSN 2327-204X
    ISSN 2327-204X
    DOI 10.13188/2327-204X.1000020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Factors affecting the choice of antibiotics in mixed infections.

    Tally, F P

    The Journal of antimicrobial chemotherapy

    1988  Volume 22 Suppl A, Page(s) 87–100

    Abstract: Mixed infections can occur anywhere in the body and, on the basis of the location of the infection, involve predictable species of anaerobic bacteria. Most of our knowledge of anaerobic mixed infection has come from the study of intra-abdominal ... ...

    Abstract Mixed infections can occur anywhere in the body and, on the basis of the location of the infection, involve predictable species of anaerobic bacteria. Most of our knowledge of anaerobic mixed infection has come from the study of intra-abdominal infections. The mortality associated with intra-abdominal abscesses in a recent study was lower than in earlier studies, perhaps because of improvements in radiographic techniques for better localization of abscess and early drainage, improved management of nutrition, and the selection of appropriate antimicrobial agents. The efficacy of an antimicrobial agent depends on its ability to penetrate into an abscess and function under conditions of low pH, low Eh and in the presence of beta-lactamases. Some effective antibiotics include clindamycin/gentamicin, metronidazole/gentamicin, latamoxef, cefoxitin, piperacillin and imipenem.
    MeSH term(s) Abscess/drug therapy ; Anti-Bacterial Agents/therapeutic use ; Bacteria, Aerobic/isolation & purification ; Bacteria, Anaerobic/isolation & purification ; Bacterial Infections/drug therapy ; Drug Resistance, Microbial ; Humans
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 1988-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 191709-2
    ISSN 1460-2091 ; 0305-7453
    ISSN (online) 1460-2091
    ISSN 0305-7453
    DOI 10.1093/jac/22.supplement_a.87
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Development of daptomycin for gram-positive infections.

    Tally, F P / DeBruin, M F

    The Journal of antimicrobial chemotherapy

    2000  Volume 46, Issue 4, Page(s) 523–526

    MeSH term(s) Animals ; Anti-Bacterial Agents/chemistry ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Daptomycin/chemistry ; Daptomycin/pharmacology ; Daptomycin/therapeutic use ; Drug Evaluation, Preclinical ; Gram-Positive Bacteria/drug effects ; Gram-Positive Bacterial Infections/drug therapy ; Humans
    Chemical Substances Anti-Bacterial Agents ; Daptomycin (NWQ5N31VKK)
    Language English
    Publishing date 2000-10
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 191709-2
    ISSN 1460-2091 ; 0305-7453
    ISSN (online) 1460-2091
    ISSN 0305-7453
    DOI 10.1093/jac/46.4.523
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Therapeutic approaches to anaerobic infection.

    Tally, F P

    Hospital practice (Office ed.)

    1981  Volume 16, Issue 12, Page(s) 117–24, 129–32

    MeSH term(s) Aminoglycosides/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/drug therapy ; Carbenicillin/therapeutic use ; Cefoxitin/therapeutic use ; Cephamycins/therapeutic use ; Chloramphenicol/therapeutic use ; Clindamycin/therapeutic use ; Drug Combinations ; Female ; Gastrointestinal Diseases/drug therapy ; Genital Diseases, Female/drug therapy ; Gram-Negative Anaerobic Bacteria ; Humans ; Male ; Moxalactam ; Respiratory Tract Infections/drug therapy ; Skin Diseases, Infectious/drug therapy ; Suppuration ; Ticarcillin/therapeutic use
    Chemical Substances Aminoglycosides ; Anti-Bacterial Agents ; Cephamycins ; Drug Combinations ; Clindamycin (3U02EL437C) ; Chloramphenicol (66974FR9Q1) ; Cefoxitin (6OEV9DX57Y) ; Ticarcillin (F93UJX4SWT) ; Carbenicillin (G42ZU72N5G) ; Moxalactam (VUF6C936Z3)
    Language English
    Publishing date 1981-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2570453-9
    ISSN 2377-1003 ; 8750-2836 ; 2154-8331
    ISSN (online) 2377-1003
    ISSN 8750-2836 ; 2154-8331
    DOI 10.1080/21548331.1981.11946885
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature.

    LaFlamme, Christy W / Rastin, Cassandra / Sengupta, Soham / Pennington, Helen E / Russ-Hall, Sophie J / Schneider, Amy L / Bonkowski, Emily S / Almanza Fuerte, Edith P / Galey, Miranda / Goffena, Joy / Gibson, Sophia B / Allan, Talia J / Nyaga, Denis M / Lieffering, Nico / Hebbar, Malavika / Walker, Emily V / Darnell, Daniel / Olsen, Scott R / Kolekar, Pandurang /
    Djekidel, Nahdir / Rosikiewicz, Wojciech / McConkey, Haley / Kerkhof, Jennifer / Levy, Michael A / Relator, Raissa / Lev, Dorit / Lerman-Sagie, Tally / Park, Kristen L / Alders, Marielle / Cappuccio, Gerarda / Chatron, Nicolas / Demain, Leigh / Genevieve, David / Lesca, Gaetan / Roscioli, Tony / Sanlaville, Damien / Tedder, Matthew L / Hubshman, Monika Weisz / Ketkar, Shamika / Dai, Hongzheng / Worley, Kim Carlyle / Rosenfeld, Jill A / Chao, Hsiao-Tuan / Neale, Geoffrey / Carvill, Gemma L / Wang, Zhaoming / Berkovic, Samuel F / Sadleir, Lynette G / Miller, Danny E / Scheffer, Ingrid E / Sadikovic, Bekim / Mefford, Heather C

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: Sequence-based genetic testing currently identifies causative genetic variants in ∼50% of individuals with developmental and epileptic encephalopathies (DEEs). Aberrant changes in DNA methylation are implicated in various neurodevelopmental disorders but ...

    Abstract Sequence-based genetic testing currently identifies causative genetic variants in ∼50% of individuals with developmental and epileptic encephalopathies (DEEs). Aberrant changes in DNA methylation are implicated in various neurodevelopmental disorders but remain unstudied in DEEs. Rare epigenetic variations ("epivariants") can drive disease by modulating gene expression at single loci, whereas genome-wide DNA methylation changes can result in distinct "episignature" biomarkers for monogenic disorders in a growing number of rare diseases. Here, we interrogate the diagnostic utility of genome-wide DNA methylation array analysis on peripheral blood samples from 516 individuals with genetically unsolved DEEs who had previously undergone extensive genetic testing. We identified rare differentially methylated regions (DMRs) and explanatory episignatures to discover causative and candidate genetic etiologies in 10 individuals. We then used long-read sequencing to identify DNA variants underlying rare DMRs, including one balanced translocation, three CG-rich repeat expansions, and two copy number variants. We also identify pathogenic sequence variants associated with episignatures; some had been missed by previous exome sequencing. Although most DEE genes lack known episignatures, the increase in diagnostic yield for DNA methylation analysis in DEEs is comparable to the added yield of genome sequencing. Finally, we refine an episignature for
    Language English
    Publishing date 2023-10-12
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.10.11.23296741
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.

    Vergote, Ignace / Pérez-Fidalgo, Jose Alejandro / Hamilton, Erika Paige / Valabrega, Giorgio / Van Gorp, Toon / Sehouli, Jalid / Cibula, David / Levy, Tally / Welch, Stephen / Richardson, Debra L / Guerra, Eva M / Scambia, Giovanni / Henry, Stéphanie / Wimberger, Pauline / Miller, David S / Klat, Jaroslav / Martínez-Garcia, Jerónimo / Raspagliesi, Francesco / Pothuri, Bhavana /
    Romero, Ignacio / Bergamini, Alice / Slomovitz, Brian / Schochter, Fabienne / Høgdall, Estrid / Fariñas-Madrid, Lorena / Monk, Bradley J / Michel, Dayana / Kauffman, Michael G / Shacham, Sharon / Mirza, Mansoor Raza / Makker, Vicky

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2023  Volume 41, Issue 35, Page(s) 5400–5410

    Abstract: Purpose: Selinexor inhibits exportin-1 (XPO1) resulting in nuclear accumulation of tumor suppressor proteins including p53 and has clinical activity in endometrial cancer (EC). The primary end point was to assess progression-free survival (PFS) with ... ...

    Abstract Purpose: Selinexor inhibits exportin-1 (XPO1) resulting in nuclear accumulation of tumor suppressor proteins including p53 and has clinical activity in endometrial cancer (EC). The primary end point was to assess progression-free survival (PFS) with once-weekly oral selinexor in patients with advanced or recurrent EC.
    Patients and methods: ENGOT-EN5/GOG-3055/SIENDO was a randomized, prospective, multicenter, double-blind, placebo-controlled, phase III study at 107 sites in 10 countries. Patients 18 years or older with histologically confirmed EC were enrolled. All had completed a single line of at least 12 weeks of taxane-platinum combination chemotherapy and achieved partial or complete response. Patients were assigned to receive 80 mg oral selinexor once weekly or placebo with 2:1 random assignment (ClinicalTrials.gov identifier: NCT03555422).
    Results: Between January 2018 and December 2021, 263 patients were randomly assigned, with 174 allocated to selinexor and 89 to placebo. The median PFS was 5.7 months (95% CI, 3.81 to 9.20) with selinexor versus 3.8 months (95% CI, 3.68 to 7.39) with placebo (hazard ratio [HR], 0.76 [95% CI, 0.54 to 1.08]; two-sided
    Conclusion: The significance level for PFS was only met in the audited analysis. However, a preliminary analysis of a prespecified exploratory subgroup of patients with
    MeSH term(s) Humans ; Female ; Prospective Studies ; Hydrazines/adverse effects ; Triazoles/adverse effects ; Endometrial Neoplasms/drug therapy ; Double-Blind Method ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
    Chemical Substances selinexor (31TZ62FO8F) ; Hydrazines ; Triazoles
    Language English
    Publishing date 2023-09-05
    Publishing country United States
    Document type Randomized Controlled Trial ; Multicenter Study ; Clinical Trial, Phase III ; Journal Article
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.22.02906
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Factors affecting antimicrobial agents in an anaerobic abscess.

    Tally, F P

    The Journal of antimicrobial chemotherapy

    1978  Volume 4, Issue 4, Page(s) 299–302

    MeSH term(s) Abscess/drug therapy ; Abscess/microbiology ; Anaerobiosis ; Anti-Bacterial Agents/therapeutic use ; Bacteroides fragilis/drug effects ; Humans ; Penicillin Resistance ; Penicillins/pharmacology ; beta-Lactamases/metabolism
    Chemical Substances Anti-Bacterial Agents ; Penicillins ; beta-Lactamases (EC 3.5.2.6)
    Language English
    Publishing date 1978-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 191709-2
    ISSN 1460-2091 ; 0305-7453
    ISSN (online) 1460-2091
    ISSN 0305-7453
    DOI 10.1093/jac/4.4.299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Acute visceral pain relief mediated by A3AR agonists in rats: involvement of N-type voltage-gated calcium channels.

    Lucarini, Elena / Coppi, Elisabetta / Micheli, Laura / Parisio, Carmen / Vona, Alessia / Cherchi, Federica / Pugliese, Anna M / Pedata, Felicita / Failli, Paola / Palomino, Seph / Wahl, Jared / Largent-Milnes, Tally M / Vanderah, Todd W / Tosh, Dilip K / Jacobson, Kenneth A / Salvemini, Daniela / Ghelardini, Carla / Di Cesare Mannelli, Lorenzo

    Pain

    2020  Volume 161, Issue 9, Page(s) 2179–2190

    Abstract: Abstract: Pharmacological tools for chronic visceral pain management are still limited and inadequate. A3 adenosine receptor (A3AR) agonists are effective in different models of persistent pain. Recently, their activity has been related to the block of ... ...

    Abstract Abstract: Pharmacological tools for chronic visceral pain management are still limited and inadequate. A3 adenosine receptor (A3AR) agonists are effective in different models of persistent pain. Recently, their activity has been related to the block of N-type voltage-gated Ca2+ channels (Cav2.2) in dorsal root ganglia (DRG) neurons. The present work aimed to evaluate the efficacy of A3AR agonists in reducing postinflammatory visceral hypersensitivity in both male and female rats. Colitis was induced by the intracolonic instillation of 2,4-dinitrobenzenesulfonic acid (DNBS; 30 mg in 0.25 mL 50% EtOH). Visceral hypersensitivity was assessed by measuring the visceromotor response and the abdominal withdrawal reflex to colorectal distension. The effects of A3AR agonists (MRS5980 and Cl-IB-MECA) were evaluated over time after DNBS injection and compared to that of the selective Cav2.2 blocker PD173212, and the clinically used drug linaclotide. A3AR agonists significantly reduced DNBS-evoked visceral pain both in the postinflammatory (14 and 21 days after DNBS injection) and persistence (28 and 35 days after DNBS) phases. Efficacy was comparable to effects induced by linaclotide. PD173212 fully reduced abdominal hypersensitivity to control values, highlighting the role of Cav2.2. The effects of MRS5980 and Cl-IB-MECA were completely abolished by the selective A3AR antagonist MRS1523. Furthermore, patch-clamp recordings showed that A3AR agonists inhibited Cav2.2 in dorsal root ganglia neurons isolated from either control or DNBS-treated rats. The effect on Ca2+ current was PD173212-sensitive and prevented by MRS1523. A3AR agonists are effective in relieving visceral hypersensitivity induced by DNBS, suggesting a potential therapeutic role against abdominal pain.
    MeSH term(s) Adenosine A3 Receptor Agonists ; Animals ; Calcium Channels, N-Type ; Female ; Ganglia, Spinal ; Male ; Pain Management ; Rats ; Visceral Pain/drug therapy
    Chemical Substances Adenosine A3 Receptor Agonists ; Calcium Channels, N-Type
    Language English
    Publishing date 2020-07-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 193153-2
    ISSN 1872-6623 ; 0304-3959
    ISSN (online) 1872-6623
    ISSN 0304-3959
    DOI 10.1097/j.pain.0000000000001905
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Antimicrobial resistance in anaerobes.

    Rasmussen, B A / Bush, K / Tally, F P

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    1997  Volume 24 Suppl 1, Page(s) S110–20

    Abstract: The development of antibiotic resistance in anaerobic bacteria has a tremendous impact on the selection of antimicrobial agents for empirical therapy. Susceptibility studies have documented the emergence of antimicrobial resistance and indicate distinct ... ...

    Abstract The development of antibiotic resistance in anaerobic bacteria has a tremendous impact on the selection of antimicrobial agents for empirical therapy. Susceptibility studies have documented the emergence of antimicrobial resistance and indicate distinct differences in resistance patterns related to individual hospitals, geographic regions, and antibiotic-prescribing regimens. Resistance to beta-lactam drugs, clindamycin, tetracyclines, and 5-nitroimidazoles (metronidazole) has been observed. The prime mechanism for resistance to beta-lactam agents is the production of beta-lactamases. Resistance to clindamycin is mediated by modification of the ribosome. Tetracycline resistance is mediated by both tetracycline efflux and ribosomal protection. 5-Nitroimidazole resistance appears to be caused by a combination of decreased antibiotic uptake and decreased nitroreductase activity. The level of chloramphenicol susceptibility remains quite high, whereas uniform resistance to aminoglycosides and quinolones is observed. Understanding the mechanisms of resistance is critical for both informed selection of antimicrobial therapy and the design of new antimicrobial agents.
    MeSH term(s) Bacteria, Anaerobic/drug effects ; Bacterial Infections/drug therapy ; Bacteroides/drug effects ; Bacteroides Infections/drug therapy ; Drug Resistance, Microbial ; Humans
    Language English
    Publishing date 1997-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/clinids/24.supplement_1.s110
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top